Skip to content
    UHS
    Earnings call· Jun 2026(Q2 FY26)

    UNIVERSAL HEALTH SERVICES Q2 FY26 earnings call UHS

    Jul 28, 2026 Source

    Executive summary

    Universal Health Services Q2 FY26 — Strong Acute Care Rebound, Strategic Capacity Expansion, and Share Buyback Acceleration

    Universal Health Services delivered a mixed Q2 FY26, marked by a strong rebound in Acute Care volumes and strategic capacity expansions, alongside accelerated share repurchases. However, the quarter's adjusted EBITDA fell short of internal expectations due to increased professional liability reserves and operational challenges at specific facilities, leading to a revised full-year outlook. The company remains committed to investing in high-growth markets and expanding access to care, with the pending Talkspace acquisition poised to enhance its behavioral health outpatient offerings.

    Highlights

    5

    • Adjusted EPS grew 12% year-over-year to $5.98 in Q2 FY26.

    • Acute Care same-facility adjusted admissions increased 2.9% year-over-year, with net revenue up 8.2%.

    • Behavioral Health same-facility net revenue increased 7.4%, driven by a 6.1% increase in revenue per adjusted patient day.

    • Accelerated share repurchases to $320 million in Q2 FY26, with $978 million remaining authorization.

    • Added 177 licensed beds in Acute Care, a 2.5% increase in same-facility capacity, and opened Alan B. Miller Medical Center in Palm Beach Gardens.

    Concerns

    5

    • Q2 adjusted EBITDA less NCI fell short of internal expectations by approximately $63 million due to higher professional liability reserves, San Antonio facility losses, and slower Cedar Hill ramp-up.

    • Full-year adjusted EBITDA less NCI guidance reduced by $50 million at the midpoint, primarily due to $200 million of adverse items.

    • Increased professional and general liability expense estimate for FY26 by $50 million, reflecting industry-wide higher claim severity.

    • San Antonio behavioral facility incurred $10 million in pretax losses in Q2 FY26 and expects $5 million-$10 million quarterly losses for the rest of 2026 due to recertification issues.

    • Acute Care and Behavioral Health full-year volume guidance fine-tuned downwards, reflecting recent performance.

    Guidance & targets

    14
    CategoryTargetConfidence
    Adjusted EPS
    6% growth
    high materiality
    High
    Revenue growth
    7% growth
    high materiality
    High
    Adjusted EBITDA less NCI growth
    3% growth
    high materiality
    High
    Adjusted EBITDA less NCI
    $2.61 billion to $2.72 billion
    high materiality
    High
    Acute Care adjusted admissions growth
    1.5% to 2.5%
    medium materiality
    Medium
    Behavioral Health adjusted patient days growth
    1.0% to 2.0%
    medium materiality
    Medium
    Full-year pretax exchange impact
    Approximately $85 million
    medium materiality
    High
    Medicaid supplemental funding net benefit
    Approximately $1.5 billion
    high materiality
    High
    Texas behavioral health facility impact
    $50 million
    medium materiality
    High
    Cedar Hill Regional Medical Center tailwind
    $20 million
    medium materiality
    High
    Professional and general liability expense increase
    Approximately $50 million
    medium materiality
    High
    San Antonio behavioral facility recertification
    Anticipated in 2027
    medium materiality
    Medium
    Talkspace acquisition closure
    Mid-August of this year
    high materiality
    High
    Share repurchase activity
    Remain highly active
    high materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Acute Care
    Volume performance improved sequentially from Q1 FY26 and was broad-based geographically. Payer mix trends consistent with recent quarters, with stronger growth in Medicare and Managed Medicare, modest growth in managed care (excluding exchanges), and slightly lower Medicaid volumes. Experienced positive trends in higher acuity inpatient service lines like urology, neurology, and cardiology.
    Same-facility adjusted admissions growth: +2.9% YoYSame-facility emergency department visits growth: +4% YoYSame-facility surgeries growth: -0.8% YoYSame-facility net revenue growth (excluding health plan): +5.9% YoYSame-facility revenue per adjusted admission growth (reported): +3.0% YoYSame-facility revenue per adjusted admission growth (excluding net out-of-period Medicaid supplemental benefits): +2.7% YoYSame-facility salaries, wages, and benefits expense per adjusted admission growth: +2.7% YoYSupply expense per adjusted admission growth: -2.5% YoYContract labor as % of revenue: 2.5%Contract labor change: 20 bps lower YoYSame-facility segment EBITDA growth (excluding out-of-period supplemental program benefit): +6.3% YoY
    		Increased 8.2%+8.2%—EBITDA growth 8.2%
    Behavioral Health
    Headcount growth moderated to 2% from 3% sequentially. Remains on track with $35 million impact from California nurse staffing ratio requirements.
    Same-facility revenue per adjusted patient day growth: +6.1% YoYSame-facility adjusted patient days growth: +1.4% YoYSame-facility revenue per adjusted patient day growth (excluding net benefit from out-of-period supplemental payments): +5.3% YoYSame-facility segment EBITDA growth (excluding net benefit from out-of-period supplemental payments): +5.7% YoYSalaries, wages, and benefits per adjusted patient day growth: +4.8% YoYHeadcount growth: 2%
    		Increased 7.4%+7.4%—EBITDA growth 9.0%

    Operational metrics

    28
    Adjusted EPS
    $5.9812% growth YoY
    Q2 FY26
    Adjusted EBITDA less NCI
    $678 million5% growth YoY
    Q2 FY26
    Q2 Adjusted EBITDA less NCI shortfall vs. expectations
    $63 million
    Q2 FY26

    This amount represents the primary drivers for the shortfall in Q2 adjusted EBITDA less NCI compared to internal expectations.

    Professional and general liability reserves increase
    $28 million
    Q2 FY26

    Part of the $63 million Q2 EBITDA shortfall and $50 million full-year increase.

    San Antonio behavioral facility pretax losses
    $10 million
    Q2 FY26

    Due to facility being in process of recertification and not receiving reimbursement.

    San Antonio behavioral facility operating losses (expected)
    $5 million to $10 million
    Per quarter

    Expected for the balance of 2026 while facility operates with limited patient census.

    San Antonio behavioral facility EBITDA (prior year)
    $25 million
    CY25

    Reference point for the facility's prior performance before recertification issues.

    Cedar Hill performance improvement
    $15 millionYoY
    Q2 FY26

    Improvement year-over-year, though results were similar to Q1.

    Acute Care net out-of-period supplemental payments
    $7 million
    Q2 FY26
    Health insurance exchange impact
    $20 million
    Q2 FY26

    In line with expectations for the quarter.

    Exchange volumes decline
    15%YoY
    Q2 FY26

    Compared to Q2 FY25.

    Behavioral Health net out-of-period supplemental payments
    $18 million
    Q2 FY26
    Cash generated from operating activities
    $44.3 millionvs. $549 million in Q2 FY25
    Q2 FY26
    Capital expenditures
    $228 million
    Q2 FY26

    Reflecting de novo hospital opening and bed capacity expansions.

    Shares repurchased
    1.89 million
    Q2 FY26

    Accelerated from $127 million in Q1 FY26.

    Share repurchase authorization available
    $978 million
    As of June 30, 2026

    Pursuant to stock buyback program.

    Cash balance
    $139 million
    As of June 30, 2026
    Total debt
    $4.85 billion
    As of June 30, 2026
    Net leverage
    1.8x
    As of June 30, 2026
    Additional borrowing capacity (revolving credit facility)
    $1.27 billion
    As of June 30, 2026
    California nurse staffing ratio requirements impact
    $35 million
    FY26

    Company remains on track with this impact contemplated in original 2026 outlook.

    Professional fees annual increase
    7-9%
    Annually

    Expected inflationary or slightly higher than inflationary uptick.

    Freestanding EDs operating
    Approximately 40
    Current

    Among the best investments in the last 5-year period.

    Freestanding EDs in development
    5 to 10
    Current
    New licensed beds added
    177
    Q2 FY26

    Added across 3 hospitals.

    New licensed beds as % of same-facility capacity
    2.5%
    Q2 FY26

    Increase to same-facility bed capacity.

    Share repurchase target
    $800 million to $900 million
    FY26

    Company expects to meet or exceed this target.

    Exchange impact prior estimate
    $75 million
    FY26

    Original estimate for full-year pretax impact, now revised to $85 million.

    Industry KPIs

    5
    MetricValueDetails
    Utilization trendsAcute Care adjusted admissions +2.9%; Acute Care emergency department visits +4%; Acute Care surgeries -0.8%; Behavioral Health adjusted patient days +1.4%%; %; %; %
    Same facility volumesAcute Care adjusted admissions +2.9%; Acute Care emergency department visits +4%; Acute Care surgeries -0.8%; Behavioral Health adjusted patient days +1.4%%; %; %; %
    Payer mix supplemental payments$1.5 billionUSD
    Segment revenue operating incomeAcute Care net revenue +8.2%; Acute Care segment EBITDA +8.2%; Behavioral Health net revenue +7.4%; Behavioral Health segment EBITDA +9.0%%; %; %; %
    Adjusted EPS EBITDA leverage guidance$5.98 Adjusted EPS; $678 million Adjusted EBITDA less NCI; 1.8x Net LeverageUSD; USD; x

    Deals & partnerships

    1
    TalkspaceIntegration planning for pending acquisition to accelerate presence in outpatient market and create end-to-end continuum of behavioral health care services.

    Within our Behavioral Health segment, we continue to make strong progress in our integration planning for the pending Talkspace acquisition, which we expect to close in mid-August of this year. Talkspace represents not only a unique opportunity for us to accelerate our presence in the outpatient market, but also creates the nation's first end-to-end continuum of behavioral health care services, from acute inpatient and residential services, inpatient, in-person, outpatient care and soon with Talkspace virtual services nationally.

    Risks & headwinds

    6
    Higher Professional and General Liability ReservesQ2 FY26 and ongoing for FY26

    $28 million impact in Q2 FY26; $50 million increase for full year FY26

    Mitigation: Internal risk management programs to reduce negative outcomes; industry lobbying for malpractice and tort reform.

    San Antonio Behavioral Facility Recertification IssuesQ2 FY26 through 2027 (recertification anticipated)

    $10 million pretax losses in Q2 FY26; expected $5 million to $10 million operating losses per quarter for H2 FY26; loss of $30 million in earnings originally budgeted for FY26

    Mitigation: Working towards recertification; facility will operate with limited patient census in the interim.

    Slower Ramp-up of Cedar Hill Regional Medical CenterOngoing through FY26 (breakeven expected Q4 FY26)

    $15 million impact in Q2 FY26 (relative to original expectations); full-year tailwind adjusted from $50 million to $20 million

    Mitigation: Building up the physician component in the region; long-term view of prospects remains positive.

    Health Insurance Exchange Volume Decline and Shift to Self-PayQ2 FY26 and ongoing for FY26

    Exchange volumes declined approximately 15% YoY in Q2 FY26; full-year pretax impact estimated at $85 million (up from $75 million)

    Mitigation: Monitoring trends and acknowledging the shift; no explicit mitigation strategy stated beyond this.

    Continued Shift to Outpatient ProceduresOngoing

    Acute Care same-facility surgeries decreased 0.8% YoY

    Mitigation: Investing in ambulatory surgery centers, expanding own outpatient surgical capacity, investing in revenue-producing equipment (robotics, advanced imaging).

    OBBA Legislation Impact on Medicaid ReimbursementBeginning 2028

    Not quantified for UHS specifically, but noted as a future pressure

    Mitigation: Strong expense management, technology investments for productivity and revenue cycle, managing exposure to Medicare in Behavioral Health by emphasizing outpatient growth.

    What to watch in Q3 FY26

    5

    Talkspace Acquisition Closure & Integration

    Q3 FY26
    CurrentIntegration planning in progress, expected to close mid-August.
    TargetAcquisition closed, initial integration steps outlined, and early impact on outpatient growth discussed.

    Why it matters

    This acquisition is expected to significantly accelerate UHS's outpatient behavioral health presence and create an end-to-end continuum of care, impacting future growth.

    Within our Behavioral Health segment, we continue to make strong progress in our integration planning for the pending Talkspace acquisition, which we expect to close in mid-August of this year.

    Q&A highlights

    6

    Is the fine-tuning of Acute Care volume guidance due to non-ACA related pressure in the base business, and what are the drivers?

    Steve Filton stated the adjustment reflects first-half performance and a continued shift of elective/outpatient procedures to alternate sites (ASCs, freestanding imaging). He noted Q2 volumes and surgical volumes rebounded, and the company is pleased with overall Q2 growth.

    “I think we're seeing continued shift of certain elective and outpatient procedures into alternate site settings, ASCs, freestanding imaging, et cetera. And I think that's the primary contribution.”

    asked by Ann Hynes · answered by Steve Filton

    2 min read6 chapters

    Detailed Narrative

    01

    Capacity Expansion & De Novo Hospitals

    UHS added 177 licensed beds across three Acute Care hospitals in Q2 FY26, representing a 2.5% increase in same-facility bed capacity. The Alan B. Miller Medical Center in Palm Beach Gardens, Florida, opened in May and achieved Joint Commission accreditation in July, with start-up losses in line with expectations. Cedar Hill Regional Medical Center in Washington, D.C., continues to ramp slower than expected, with its breakeven now anticipated in Q4 FY26, impacting the full-year tailwind from $50 million to $20 million.

    02

    Behavioral Health Strategy & Talkspace Integration

    The company is making strong progress in integrating the pending Talkspace acquisition, expected to close in mid-August. This acquisition aims to accelerate UHS's presence in the outpatient market and create an end-to-end continuum of behavioral health services, from inpatient to virtual care. Management believes Talkspace's panel of over 6,000 therapists will address capacity limitations for follow-up care and accelerate outpatient growth.

    03

    Medicaid Supplemental Funding

    The approval of the Florida DPP program for 2025, not originally contemplated, provided a significant benefit in Q2 FY26. The full-year Medicaid supplemental funding net benefit is now expected to be approximately $1.5 billion, an increase of $150 million from the prior outlook, with over one-fifth derived from state-based programs not subject to OBBA legislation.

    04

    Professional & General Liability Reserves

    UHS increased its professional and general liability reserves by $28 million in Q2 FY26, contributing to a $50 million increase for the full year. This reflects industry-wide trends of higher claim severity across all healthcare settings and is based on semiannual third-party actuarial reviews.

    05

    San Antonio Behavioral Facility Challenges

    A behavioral health hospital in San Antonio, Texas, is undergoing recertification, leading to a halt in reimbursement since April. The facility incurred $10 million in pretax losses in Q2 FY26 and is expected to incur $5 million to $10 million in quarterly losses for the remainder of 2026. Recertification is anticipated in 2027, and the facility will operate with limited patient census in the interim.

    06

    Capital Allocation & Share Repurchase

    UHS accelerated its share repurchase activity in Q2 FY26, buying back 1.89 million shares for $320 million, compared to $127 million in Q1 FY26. With $978 million of authorization remaining, the company intends to remain highly active, viewing the current share price as a compelling opportunity. Capital allocation continues to emphasize organic capital spending, outpatient investments (freestanding EDs, behavioral clinics), and share repurchases.

    AI-generated summary of the company’s earnings call. Not investment advice.